Sequent Scientific Limited (NSE:SEQUENT)
India · Delayed Price · Currency is INR 168.61
-3.36 (-1.95%)
Aug 1, 2025, 3:30 PM IST
Accolade Market Cap
Sequent Scientific has a market cap or net worth of 42.07 billion as of August 1, 2025. Its market cap has increased by 17.45% in one year.
Market Cap
42.07B
Enterprise Value
46.92B
Revenue
15.51B
Ranking
n/a
PE Ratio
192.31
Stock Price
$168.61
Market Cap Chart
Since January 5, 2005, Sequent Scientific's market cap has increased from 347.75M to 42.07B, an increase of 11,999.06%. That is a compound annual growth rate of 26.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 42.07B | -4.33% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | 41.50B | 140.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,094.94B |
| Divi's Laboratories | 1,750.90B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,059.56B |
| Zydus Lifesciences | 975.85B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 647.34B |